VALIDATION OF THE PCA3 MOLECULAR URINE TEST FOR PREDICTING REPEAT PROSTATE BIOPSY OUTCOME IN THE PLACEBO ARM OF THE DUTASTERIDE REDUCE TRIAL

被引：0
|
作者：
Marks, Leonard
Aubin, Sheila
Reid, Jennifer
Sarno, Mark
Blase, Amy
Aussie, Jacqueline
Rittenhouse, Harry
Andriole, Gerald
Rittmaster, Roger
Groskopf, Jack
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.2207
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
2119
引用
收藏
页码：E823 / E823
页数：1
相关论文
共 50 条
  • [41] CAN PROSTATE CANCER GENE 3 (PCA3) PREDICT INITIAL BIOPSY OUTCOME?
    de la Taille, Alexandre
    Irani, Jacques
    de Reijke, Theo M.
    Haese, Alexander
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 655 - 655
  • [42] CLINICAL UTILITY OF PCA3 URINE ASSAY IN JAPANESE MEN UNDERGOING PROSTATE BIOPSY
    Ochiai, Atsushi
    Okihara, Koji
    Kamoi, Kazumi
    Oikawa, Takehiro
    Shimazui, Toru
    Murayama, Shinichiro
    Tomita, Kyoichi
    Umekawa, Tohru
    Uemura, Hirotsugu
    Miki, Tsuneharu
    [J]. JOURNAL OF UROLOGY, 2013, 189 (04): : E915 - E915
  • [43] CLINICAL UTILITY OF PCA3 URINE ASSAY IN JAPANESE MEN UNDERGOING PROSTATE BIOPSY
    Ochiai, A.
    Okihara, K.
    Kamoi, K.
    Shimazui, T.
    Akaza, H.
    Murayama, S.
    Tomita, K.
    Umekawa, T.
    Umemura, H.
    Miki, T.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 174 - 175
  • [44] Utility of PCA3 urine assay in Japanese men undergoing prostate biopsy.
    Okihara, K.
    Ochiai, A.
    Kamoi, K.
    Miki, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [45] The PCA3 score is independent of prostate gland volume, and can synergize with other patient information for predicting biopsy outcome
    Groskopf, Jack
    Deras, Ina L.
    Blase, Amy
    Aubin, Sheila M. J.
    Koo, Seongjoon
    Fradet, Yves
    Marks, Leonard S.
    Rittenhouse, Harry
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 568 - 568
  • [46] PREDICTING PROSTATE BIOPSY OUTCOME IN A SCREENING SETTING PSA, PCA3, A KALLIKREIN PANEL, THE RISKCALCULATOR OR A COMBINATION? ERSPC ROTTERDAM
    Roobol, M. J.
    Hessels, D.
    Vickers, A. J.
    Schalken, J. A.
    Van Leeuwen, P.
    Wolters, T.
    Van Den Bergh, R. C. N.
    Schroder, F. H.
    Lilja, H.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 305 - 306
  • [47] Prostate Cancer Gene 3 (PCA3): Development and Internal Validation of a Novel Biopsy Nomogram
    Chun, Felix K.
    de la Taille, Alexandre
    van Poppel, Hendrik
    Marberger, Michael
    Stenzl, Arnulf
    Mulders, Peter F. A.
    Huland, Hartwig
    Abbou, Clement-Claude
    Stillebroer, Alexander B.
    van Gils, Martijn P. M. Q.
    Schalken, Jack A.
    Fradet, Yves
    Marks, Leonard S.
    Ellis, William
    Partin, Alan W.
    Haese, Alexander
    [J]. EUROPEAN UROLOGY, 2009, 56 (04) : 659 - 667
  • [48] The PCA3 score is independent of prostate gland volume, and can synergize with other patient information for predicting biopsy outcome
    Groskopf, J.
    Blase, A.
    Koo, S.
    Deras, I. L.
    Aubin, S. M. J.
    Marks, L.
    Fradet, Y.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 48 - 48
  • [49] Predicting prostate cancer risk through incorporation of a molecular biomarker: PCA3
    Ankerst, Donna Pauler
    Groskopf, Jack
    Day, John R.
    Blase, Amy
    Rittenhouse, Harry
    Pollock, Brad H.
    Tangen, Cathy
    Parekh, Dipen
    Leach, Robin
    Thompson, Ian
    [J]. CANCER BIOMARKERS, 2008, 4 (03) : 163 - 164
  • [50] Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy
    Ochiai, Atsushi
    Okihara, Koji
    Kamoi, Kazumi
    Oikawa, Takehiro
    Shimazui, Toru
    Murayama, Shin-Ichiro
    Tomita, Kyoichi
    Umekawa, Tohru
    Uemura, Hirotsugu
    Miki, Tsuneharu
    [J]. BJU INTERNATIONAL, 2013, 111 (06) : 928 - 933
12345